These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3096788)

  • 1. Prevention of gonadotropin-releasing hormone antagonist induced luteal regression by concurrent exogenous pulsatile gonadotropin administration in monkeys.
    Collins RL; Sopelak VM; Williams RF; Hodgen GD
    Fertil Steril; 1986 Nov; 46(5):945-53. PubMed ID: 3096788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
    Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
    Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
    Fluker MR; Marshall LA; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous gonadotrophin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist.
    Weinbauer GF; Hankel P; Nieschlag E
    J Endocrinol; 1992 Jun; 133(3):439-45. PubMed ID: 1613445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of gonadotropin secretion in the ovine fetus: the effects of a specific gonadotropin-releasing hormone antagonist on pulsatile luteinizing hormone secretion.
    Matwijiw I; Faiman C
    Endocrinology; 1987 Jul; 121(1):347-51. PubMed ID: 3297644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation.
    Frydman R; Cornel C; de Ziegler D; Taieb J; Spitz IM; Bouchard P
    Fertil Steril; 1991 Nov; 56(5):923-7. PubMed ID: 1936328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of luteinizing hormone in the expression of cholesterol side-chain cleavage cytochrome P450 and 3 beta-hydroxysteroid dehydrogenase, delta 5-4 isomerase messenger ribonucleic acids in the primate corpus luteum.
    Ravindranath N; Little-Ihrig L; Benyo DF; Zeleznik AJ
    Endocrinology; 1992 Nov; 131(5):2065-70. PubMed ID: 1425410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
    Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
    J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.
    Mais V; Kazer RR; Cetel NS; Rivier J; Vale W; Yen SS
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1250-5. PubMed ID: 3084538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of luteal regression in the marmoset monkey (Callithrix jacchus) by a gonadotrophin-releasing hormone antagonist and the effects on subsequent follicular development.
    Hodges JK; Green DI; Cottingham PG; Sauer MJ; Edwards C; Lightman SL
    J Reprod Fertil; 1988 Mar; 82(2):743-52. PubMed ID: 3129559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey.
    Webley GE; Hodges JK; Given A; Hearn JP
    J Endocrinol; 1991 Jan; 128(1):121-9. PubMed ID: 1900320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the positive feedback of estradiol benzoate on gonadotropin secretion by an inhibitory analog of luteinizing hormone-releasing hormone (LRH) in oophorectomized rhesus monkeys: evidence for a necessary synergism between LRH and estrogens.
    Asch RH; Balmaceda JP; Borghi MR; Niesvisky R; Coy DH; Schally AV
    J Clin Endocrinol Metab; 1983 Aug; 57(2):367-72. PubMed ID: 6408113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.